Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
70/100
Pipeline Velocity
30/100
Trial Completion Rate
83/100
Pipeline Concentration
100/100
Pipeline Freshness
11/100
Activity
Last 14 days
A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty
PET Imaging of Noradrenergic Transmission in the Brain
Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth
Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder
Evaluation of [11C]ZTP-1 to Image PDE4B
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer s Disease (AD) or Mild Cognitive Impairment (MCI)
State-Dependent Interoception, Value-Based Decision Making, and Introspection
An Observational Study of the Developing Brain, Impulsivity and Compulsivity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)